데이터셋 상세
미국
USDA Agricultural Research Service- Available Biological Materials
,The biological materials in this section are unpatented, proprietary intellectual property, available for licensing under a Biological Materials License Agreement: Hybridoma Cell Lines; Microbial Isolates; Cloned Genetic Material; Cell Lines; Viruses; Plasmids. Updated June 2018.,,
연관 데이터
USDA Agricultural Research Service- Patented Available Plant Cultivars
공공데이터포털
,Recent USDA/ARS patent- and PVP-protected plant cultivars that are available for licensing are described, including summary, contact, and patent number/status. Updated June 2018.,,
USDA Agricultural Research Service- Patented Crop Production and Crop Protection Technologies
공공데이터포털
,Recent USDA/ARS patented technologies on crop production and protection that are available for licensing are described, including summary, contact, benefits, and applications. Updated June 2018.,,
USDA Agricultural Research Service- Patented Animal Production and Protection Technologies
공공데이터포털
,Recent USDA/ARS patented technologies on animal production and protection that are available for licensing are described, including summary, contact, benefits, and applications. Updated June 2018.,,
USDA Agricultural Research Service- Patented Food Processing and Products Technologies
공공데이터포털
,Recent USDA/ARS patented technologies on food processing and products that are available for licensing are described, including summary, contact, benefits, and applications. Updated June 2018.,,
윕스 - [샘플] 국가첨단전략기술 - 바이오편
공공데이터포털
국가첨단전략기술 바이오 특허 데이터(서지사항 74개), 특허로 바로가기 및 패밀리정보가 담긴 웹버전 제공,,,데이터 다운로드 Build BI 이용,,
Patent AT-E401406-T1: [Translated] CHICKEN ANAEMIA VIRUS MUTANT, VACCINES, AND USES BASED ON VIRUS PROTEIN VP3, OR VIRUS SEQUENCES ENCODING THEREOF
공공데이터포털
Novel proteins of the Chicken Anemia Virus are described and compositions for preventing or treating infections with that virus (CAV), in particular vaccines less pathogenic than the CAV itself, but yet leading to neutralizing antibodies in the immunized animal. Besides, there are described compositions containing antibodies against parts of the CAV for the control of infections with CAV and anti-idiotype antibodies which possess an immunogenicity corresponding to the antigen. The invention also provides antibodies for the detection of CAV infections and test kits for the detection of CAV. Recombinant DNA molecules derived from CAV coding for an immunogenic part of a CAV protein and host cells transfected with such DNA molecules and vaccines based on these host cells are made possible by this invention. Also, living virus vaccines in which a piece of DNA coding for an immunogenic part of a CAV protein is brought into a virus infectious to the desired host are a subject of the invention. Besides, the invention relates to uses of proteins of CAV in the induction of apoptosis, in particular, the proteins can be used in induction of apoptosis in tumor cells. The invention further provides the induction of cell death by means of gene therapy.
Patent AT-E399873-T1: [Translated] DEFECTIVE ADENOVIRUS VECTORS AND THEIR USE IN GENE THERAPY
공공데이터포털
Novel adenovirus-derived viral vectors, the preparation thereof, and the use thereof in gene therapy, are disclosed.
윕스 - 국가첨단전략기술('11~'24년) - 바이오편
공공데이터포털
국가첨단전략기술 바이오 특허 데이터(서지사항 72개), 특허로 바로가기 및 패밀리정보가 담긴 웹버전 제공
Data from: The Biology of IncI2 Plasmids Shown by Whole-Plasmid Multi-Locus Sequence Typing
공공데이터포털
,DNA sequences of each allele for 165 loci found in a population of 147 fully sequenced IncI2 plasmids with allelic identifiers.,Data is based on whole-genome sequences in the National Center for Biotechnology Information database as of July, 2017.,Resources in this dataset:,,
Biotechnology Regulatory Services public data file (permits, notifications, and petitions)
공공데이터포털
Public information on BRS applications for genetically engineered permits, notifications, and petitions.